Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,451 | 6 | 81.6% |
| Travel and Lodging | $5,237 | 22 | 13.2% |
| Food and Beverage | $2,102 | 23 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $11,332 | 16 | $0 (2024) |
| GENZYME CORPORATION | $10,173 | 8 | $0 (2018) |
| Merck Sharp & Dohme LLC | $8,402 | 10 | $0 (2022) |
| Celgene Corporation | $8,170 | 6 | $0 (2018) |
| KLS-Martin L.P. | $1,713 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,612 | 11 | Regeneron Pharmaceuticals, Inc. ($10,463) |
| 2023 | $1,148 | 7 | Regeneron Pharmaceuticals, Inc. ($869.35) |
| 2022 | $8,589 | 13 | Merck Sharp & Dohme LLC ($8,402) |
| 2021 | $267.60 | 2 | KLS-Martin L.P. ($267.60) |
| 2018 | $19,174 | 18 | GENZYME CORPORATION ($10,173) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | KLS-Martin L.P. | — | Food and Beverage | Cash or cash equivalent | $149.23 | General |
| Category: Osteosynthesis | ||||||
| 01/26/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $5,190.00 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $3,460.00 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $865.00 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $461.35 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $133.83 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $112.70 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $97.64 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $53.53 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $49.31 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $39.33 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $147.38 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $330.75 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $170.72 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2023 | KLS-Martin L.P. | — | Food and Beverage | Cash or cash equivalent | $278.29 | General |
| 10/12/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $6,710.00 | General |
| 10/12/2022 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 10/07/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $555.00 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $56.81 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $336.55 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 145 | 226 | $40,340 | $10,407 |
| 2022 | 2 | 127 | 174 | $28,320 | $7,761 |
| 2021 | 2 | 133 | 182 | $27,710 | $8,241 |
| 2020 | 4 | 153 | 197 | $28,130 | $6,473 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 104 | 166 | $23,840 | $7,377 | 30.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2023 | 41 | 60 | $16,500 | $3,030 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 96 | 133 | $17,455 | $5,976 | 34.2% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2022 | 31 | 41 | $10,865 | $1,785 | 16.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 109 | 152 | $19,760 | $6,845 | 34.6% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2021 | 24 | 30 | $7,950 | $1,395 | 17.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 98 | 139 | $18,070 | $4,552 | 25.2% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2020 | 31 | 34 | $8,500 | $1,482 | 17.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 12 | 12 | $960.00 | $228.59 | 23.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 12 | 12 | $600.00 | $209.68 | 34.9% |
About James Rocco, M.D.,PHD
James Rocco, M.D.,PHD is a Plastic Surgery within the Head & Neck healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972594091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Rocco, M.D.,PHD has received a total of $39,790 in payments from pharmaceutical and medical device companies, with $10,612 received in 2024. These payments were reported across 51 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($32,451).
As a Medicare-enrolled provider, Rocco has provided services to 558 Medicare beneficiaries, totaling 779 services with total Medicare billing of $32,881. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Plastic Surgery within the Head & Neck
- Other Specialties Otolaryngology
- Location Columbus, OH
- Active Since 10/31/2005
- Last Updated 12/29/2014
- Taxonomy Code 207YX0007X
- Entity Type Individual
- NPI Number 1972594091
Products in Payments
- LIBTAYO (Biological) $11,332
- NO PRODUCT DISCUSSED (Drug) $10,173
- Tislelizumab (Drug) $7,591
- KEYTRUDA (Biological) $1,542
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.